Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Cold Blooded Criminals Use Violence Indiscriminately, UK
Psychopaths are more likely to use violence in a cold blooded, calculated way than non-psychopathic violent offenders.

Key To Potential New Treatment For Allergy-Induced Asthma Identified By Yale Team
In research that could lead to new asthma drugs, scientists at Yale School of Medicine, Hydra Biosciences of Cambridge, Massachusetts, and the University of California, San Francisco have discovered that a protein may be a trigger of allergy-induced asthma in mice. They also demonstrated how a drug known to reduce inflammatory and neuropathic pain may also inhibit asthma symptoms in mice. Their paper is published in the May 18-22 online Early Edition of the Proceedings of the National Academy of Sciences.
News of the day
Rolofylline Did Not Demonstrate Efficacy For Acute Heart Failure In Clinical Trial
Merck & Co., Inc. said that preliminary results for the pivotal Phase III study of rolofylline (MK-7418), the Company"s investigational medicine for the treatment of acute heart failure, show that rolofylline did not meet the primary or secondary efficacy endpoints. While Merck will continue to analyze the data with outside experts, the Company will not file applications for regulatory approval this year. The results from this study will be presented at a medical meeting later this year.
Oncology

Accouncing The Leading European Congress On Cardiac Arrhythmias And Pacing: EUROPACE 2009

EUROPACE, the official congress of the European Heart Rhythm Association (EHRA), is the foremost European meeting on cardiac arrhythmias and pacing. More than 4,000 participants are expected to attend this year"s event, whose main themes are atrial fibrillation and sudden cardiac death. EHRA is a registered branch of the European Society of Cardiology (ESC). Its mission is to reduce the impact of cardiac arrhythmias and sudden cardiac death (SCD). EUROPACE 2009 will be held from 21-24 June in ICC Berlin, Germany. The press conference in Berlin will highlight several themes from the EUROPACE 2009 scientific programme: * How to improve the quality of care with a more uniform treatment of arrhythmias and better prevention of sudden cardiac death in all European countries. * Cardiac arrhythmias in athletes will be another important topic. A scientific session will consider the requirement for screening of all athletes to avoid sudden cardiac death and the implications of an abnormal electrocardiogram (ECG) in an athlete. The prevalence of cardiac arrhythmias in the athlete"s heart will be debated. * Hot Line sessions will be a major feature at EUROPACE 2009 (Tuesday 23 June). Devoted to late-breaking news from clinical trials, the ESC"s Hot Line sessions are renowned for making strong stories in medical news and will be discussed at the press conference. Also presented at the press conference: * Remote monitoring * Latest facts and figures on arrhythmias in Europe * Driving with ICD * Beat-It! Campaign Notes: 1. Sudden cardiac death claims more lives than stroke, lung cancer, breast cancer and AIDS combined. Incidence is less than 1% per year in the general population, but rising to more than 30% in high-risk post-MI subgroups. 2. Cardiac arrhythmia describes conditions in which heart beat is too fast, too slow, or irregular. The cause is abnormal electrical activity in the heart. Some arrhythmias may be life-threatening and result in sudden cardiac death. The average healthy heart beats 200,000 times per day. 3. The most common arrhythmia (after a skipped beat) is atrial fibrillation, which affects up to 5 per cent of all adults, mainly the over-65s. * Information on the scientific programme for Europace 2009 is available at http://spo.escardio.org/Welcome.aspx?eevtid=32 ESC Press Office European Society of Cardiology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009